Home>Topics>European Commission

European Commission

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Headlines
  1. European Commission approves Alcon combo drug for reducing IOP

    Headlines

    Mon, 28 Jul 2014

    The European regulator approves Sandoz' (NYSE: NVS ) Simbrinza eye drops suspension ( brinzolamide 10 mg/ml and brimonidine tartrate 2mg/ml) to decrease intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension for which monotherapy provides insufficient IOP ...

  2. CHMP issues positive opinion for Roche RA drug label expansion

    Headlines

    Mon, 28 Jul 2014

    inadequately to or who are intolerant to previous therapy with one or more disease-modifying antirheumatic drugs or tumor necrosis factor antagonists. A final decision by the European Commission usually takes ~3 months. Post your comment!

  3. EU mergers and takeovers (July 28)

    Headlines

    Mon, 28 Jul 2014

    BRUSSELS, July 28 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process:

  4. Novartis says Alcon glaucoma treatment approved in EU

    Headlines

    Mon, 28 Jul 2014

    ZURICH, July 28 (Reuters) - Swiss pharmaceutical group Novartis said the European Commission has approved its eyecare unit Alcon's Simbrinza treatment for glaucoma, a chronic, sight-threatening eye disease.

  5. CHMP's positive on Imbruvica for blood cancer

    Headlines

    Fri, 25 Jul 2014

    Switzerland GmbH. Once approved, Janssen will market it exclusively in EMEA (Europe, Middle East, Africa) and co-promote it in the U.S. A final decision from the European Commission usually takes ~3 months. Post your comment!

  6. EU mergers and takeovers (July 25)

    Headlines

    Fri, 25 Jul 2014

    BRUSSELS, July 25 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process:

  7. CHMP recommends approval for Zydelig

    Headlines

    Fri, 25 Jul 2014

    Committee also supports the use of Zydelig as a monotherapy for the treatment of FL in patients refractory to two prior lines of treatment. A final decision from the European Commission typically takes ~3 months. Post your comment!

  8. Novo sees two-in-one diabetes drug in Europe in H1 2015

    Headlines

    Fri, 25 Jul 2014

    COPENHAGEN, July 25 (Reuters) - Novo Nordisk, the world's largest insulin maker, said on Friday it expected European Commission marketing authorisation for its new two-in-one insulin drug within three months after an EU medicines agency recommended the drug.

  9. EU to draw up legal text on Russia sanctions

    Headlines

    Fri, 25 Jul 2014

    BRUSSELS, July 25 (Reuters) - European Union ambassadors asked the European Commission on Friday to draw up a legal text to impose sectoral sanctions on Russia, but there is no final agreement yet to impose them, EU diplomats said.

  10. EU regulators to decide on Oracle, Micros deal by Aug. 29

    Headlines

    Fri, 25 Jul 2014

    BRUSSELS (Reuters) - European Union antitrust regulators will decide by Aug. 29 whether to clear world No. 2 software maker Oracle Corp's $5.3 billion bid for Micros Systems , the European Commission said on Friday.

« Prev12345Next »
Content Partners